Proteomics International Laboratories Ltd.ASX: PIQ

Proteomics International receives $2.2m in R&D tax incentive

· Issued by Proteomics International Laboratories Ltd.

Filed with ASX · · 2 pages · English

Summary by 6ix AI

Proteomics International Laboratories Ltd. has announced the receipt of a significant research and development tax incentive, which has bolstered its cash reserves. The company received a rebate for its R&D expenditures during the financial year, which supports its ongoing development of innovative diagnostic tests. Proteomics International is focused on advancing its diagnostic pipeline, including tests for various medical conditions using its Promarker® technology platform. This funding is part of the Australian Government's initiative to encourage beneficial research activities within the country.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Proteomics International Laboratories Ltd. on 6ix

Earlier from Proteomics International Laboratories

Later from Proteomics International Laboratories

All Proteomics International Laboratories news releases